LAUSR

Promotion of Drugs for Off-label Uses: The US Food and Drug Administration at a Crossroads.

Sign Up to like & get
recommendations!
1 Published in 2017 at "JAMA internal medicine"

DOI: 10.1001/jamainternmed.2016.7151

Abstract: Since 1962, the US Food and Drug Administration (FDA) has required companies to establish, with adequate and well-controlled clinical trials, a drug’s safety and efficacy for each intended use and has prohibited the “offlabel” promotion… read more here.

Keywords: court; evidence; drug; food drug ... See more keywords

Off-label uses of drugs for depression.

Sign Up to like & get
recommendations!
1 Published in 2019 at "European journal of pharmacology"

DOI: 10.1016/j.ejphar.2019.172732

Abstract: The prescription of drugs for depression is rising rapidly. One of the reasons for this trend is their many off-label uses. Up to one third of all prescriptions are for non-indicated use, which in addition… read more here.

Keywords: uses drugs; depression; medicine; label uses ... See more keywords

Off label uses of hyaluronic acid fillers: A review

Sign Up to like & get
recommendations!
2 Published in 2022 at "Dermatologic Therapy"

DOI: 10.1111/dth.15876

Abstract: Food and Drug Administration approved indications of hyaluronic acid fillers include some facial wrinkles or skin folds like naso‐labial folds, perioral wrinkles, volumization of lip, cheek, chin, and dorsal region of the hands, also acne… read more here.

Keywords: uses hyaluronic; fillers review; hyaluronic acid; label uses ... See more keywords

Off‐label uses of ustekinumab

Sign Up to like & get
recommendations!
1 Published in 2022 at "Dermatologic Therapy"

DOI: 10.1111/dth.15910

Abstract: Ustekinumab (brand name Stelara®) is a human interleukin‐12 and ‐23 antagonist and has been indicated for the treatments of moderate to severe plaque psoriasis, psoriatic arthritis, Crohn's disease and ulcerative colitis. This review aims to… read more here.

Keywords: uses ustekinumab; psoriasis; label uses;

Off-label uses of the Pipeline embolization device: a review of the literature.

Sign Up to like & get
recommendations!
1 Published in 2017 at "Neurosurgical focus"

DOI: 10.3171/2017.3.focus1742

Abstract: The Pipeline embolization device (PED) is the most widely used flow diverter in endovascular neurosurgery. In 2011, the device received FDA approval for the treatment of large and giant aneurysms in the internal carotid artery… read more here.

Keywords: pipeline embolization; label uses; embolization device; device ... See more keywords